Пожалуйста, войдите в систему, чтобы принять участие в дискуссии (добавить собственные рецензию, или комментарий)
Цитировать эту публикацию
%0 Journal Article
%1 Hasenclever_1995
%A Hasenclever, D.
%A Schmitz, N.
%A Diehli, V.
%D 1995
%I Informa Healthcare
%J Leukemia and Lymphoma
%K chemotherapy dose high line rationale
%P 47--49
%R 10.3109/10428199509052706
%T Is There a Rationale for High-Dose Chemotherapy as First Line Treatment of Advanced Hodgkin\textquotesingles Disease?
%U http://dx.doi.org/10.3109/10428199509052706
%V 15
@article{Hasenclever_1995,
added-at = {2014-10-07T18:28:44.000+0200},
author = {Hasenclever, D. and Schmitz, N. and Diehli, V.},
biburl = {https://www.bibsonomy.org/bibtex/23c9adacdf740b6f51f6c00f46d932f78/drtester},
description = {test3},
doi = {10.3109/10428199509052706},
interhash = {cbc08dd7ba8edca2fb538232e6731715},
intrahash = {3c9adacdf740b6f51f6c00f46d932f78},
journal = {Leukemia and Lymphoma},
keywords = {chemotherapy dose high line rationale},
month = feb,
pages = {47--49},
publisher = {Informa Healthcare},
timestamp = {2014-10-07T18:28:44.000+0200},
title = {Is There a Rationale for High-Dose Chemotherapy as First Line Treatment of Advanced Hodgkin{\textquotesingle}s Disease?},
url = {http://dx.doi.org/10.3109/10428199509052706},
volume = 15,
year = 1995
}